Company Filing History:
1 out of 250 
1 out of 2 Years Active: 2021
Title: Shuang Jiang: Innovator in Fibroblast Growth Factor Receptor Kinase Inhibitors
Introduction: Shuang Jiang is a remarkable inventor based in Guangdong, China, who has made significant contributions to the field of biomedical research. With a focus on developing innovative treatments for hyper-proliferative diseases, Jiang has earned recognition for her groundbreaking work and her sole patent.
Latest Patents: Jiang holds a patent for "FGFR kinase inhibitors and pharmaceutical uses," which encompasses Fibroblast Growth Factor Receptor kinase inhibitors and prodrugs of Formula (I). This invention holds potential in treating various debilitating conditions, including retinopathy, psoriasis, rheumatoid arthritis, osteoarthritis, and several other serious medical issues. Her work specifically addresses diseases related to abnormal cell growth, offering hope for millions affected by these conditions.
Career Highlights: Throughout her career, Shuang Jiang has been associated with reputable institutions such as Auckland Uniservices Limited and the Guangzhou Institute of Biomedicine and Health. Her experience in these organizations underscores her expertise in biomedicine and her commitment to advancing health science through her research and inventions.
Collaborations: Jiang has collaborated with notable professionals, including Adam Vorn Patterson and Jeffrey Bruce Smaill. These collaborations have likely fostered innovative ideas and furthered research initiatives, contributing to the progress in treating diseases targeted by her inventions.
Conclusion: Shuang Jiang stands out as a prominent inventor in the realm of pharmacological innovations. Her patent on FGFR kinase inhibitors reflects her dedication to addressing critical health challenges. Through her work, Jiang continues to inspire future generations of inventors and researchers in the pursuit of medical breakthroughs.